Low incidence of haematogenous seeding to total hip and knee prostheses in patients with remote infections

Journal of Infection

Volumn 59, Issue 5, 2009, Pages 337-345

  Uçkay, Ilker ^a   Lübbeke, Anne ^a   Emonet, Stéphane ^a   Tovmirzaeva, Luisa ^a   Stern, Richard ^a   Ferry, Tristan ^a   Assal, Mathieu ^a   Bernard, Louis ^a,b,c   Lew, Daniel ^a   Hoffmeyer, Pierre ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Arthroplasty; Exposure; Haematogenous; Infection; Surgical site

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIP PROSTHESIS; HOSPITAL PATIENT; HUMAN; INFECTION; INFECTION SENSITIVITY; KNEE PROSTHESIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POSTOPERATIVE COMPLICATION; PROSTHESIS INFECTION; REMOTE INFECTION; HIP ARTHROPLASTY; INCIDENCE; KNEE ARTHROPLASTY; MICROBIOLOGY; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HIP PROSTHESIS; HUMANS; INCIDENCE; KNEE PROSTHESIS; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS;

EID: 70449725157     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.08.015     Document Type: Article

References (46)

1. Phillips J.E., Crane T.P., Noy M., Elliott T.S., and Grimer R.J. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br 88 (2006) 943-948
2. Darouiche R.O. Treatment of infections associated with surgical implants. N Engl J Med 350 (2004) 1422-1429
3. Hamilton H., and Jamieson J. Deep infection in total hip arthroplasty. Can J Surg 51 (2008) 111-117
4. Charnley J. Postoperative infection after total hip replacement with special reference to air contamination in the operating room. Clin Orthop Relat Res 87 (1972) 167-187
5. Hill C., Flamant R., Mazas F., and Evrard J. Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomised trial. Lancet 1 (1981) 795-796
6. Lidwell O.M., Lowbury E.J., Whyte W., Blowers R., Stanley S.J., and Lowe D. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. BMJ 285 (1982) 10-14
7. Maniloff G., Greenwald R., Laskin R., and Singer C. Delayed postbacteremic prosthetic joint infection. Clin Orthop Relat Res 223 (1987) 194-197
8. Fitzgerald Jr. R.H., Nolan D.R., Ilstrup D.M., Van Scoy R.E., Washington II J.A., and Coventry M.B. Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg Am 59 (1977) 847-855
9. Segawa H., Tsukayama D.T., Kyle R.F., Becker D.A., and Gustilo R.B. Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections. J Bone Joint Surg Am 81 (1999) 1434-1445
10. Giulieri S.G., Graber P., Ochsner P.E., and Zimmerli W. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 32 (2004) 222-228
11. Garvin K.L., and Hanssen A.D. Infection after total hip arthroplasty. Past, present, and future. J Bone Joint Surg Am 77 (1995) 1576-1588
12. Murdoch D.R., Roberts S.A., Fowler Jr. V.G., Shah M.A., Taylor S.L., Morris A.J., et al. Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis 32 (2001) 647-649
13. Maderazo E.G., Judson S., and Pasternak H. Late infections of total joint prostheses. A review and recommendations for prevention. Clin Orthop Relat Res 229 (1988) 131-142
14. Cook J.L., Scott R.D., and Long W.J. Late hematogenous infections after total knee arthroplasty: experience with 3013 consecutive total knees. J Knee Surg 20 (2007) 27-33
15. Tsukayama D.T., Estrada R., and Gustilo R.B. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 78 (1996) 512-523
16. Zimmerli W., and Ochsner P.E. Management of infection associated with prosthetic joints. Infection 31 (2003) 99-108
17. Ching D.W., Gould I.M., Rennie J.A., and Gibson P.H. Prevention of late hematogenous infection in major prosthetic joints. J Antimicrob Chemother 23 (1989) 676-680
18. Ueng W.N., Shih C.H., and Hseuh S. Pulmonary tuberculosis as a source of infection after total hip arthroplasty. A report of two cases. Int Orthop 19 (1995) 55-59
19. Hall A.J. Late infection about a total knee prosthesis. Report of a case secondary to urinary tract infection. J Bone Joint Surg Br 56 (1974) 144-147
20. Orton D.W., and Fulcher W.H. Pasteurella multocida: bilateral septic knee joint prostheses from a distant cat bite. Ann Emerg Med 13 (1984) 1065-1067
21. McCarthy J., and Stingemore N. Clostridium difficile infection of a prosthetic joint presenting 12 months after antibiotic-associated diarrhoea. J Infect 39 (1999) 94-96
22. Wigren A., Karlstrom G., and Kaufer H. Hematogenous infection of total joint implants: a report of multiple joint infections in three patients. Clin Orthop Relat Res 152 (1980) 288-291
23. Thomas B.J., Moreland J.R., and Amstutz H.C. Infection after total joint arthroplasty from distal extremity sepsis. Clin Orthop Relat Res 181 (1983) 121-125
24. Chu V.H., Crosslin D.R., Friedman J.Y., Reed S.D., Cabell C.H., Griffiths R.I., et al. Staphylococcus aureus bacteraemia in patients with prosthetic devices: costs and outcomes. Am J Med 118 (2005) 1416
25. Duggan J.M., Georgiadis G., VanGorp C., and Kleshinski J. Group B streptococcal prosthetic joint infections. J South Orthop Assoc 10 (2001) 209-214
26. Schmalzried T.P., Amstutz H.C., Au M.K., and Dorey F.J. Etiology of deep sepsis in total hip arthroplasty. The significance of hematogenous and recurrent infections. Clin Orthop Relat Res 280 (1992) 200-207
27. Ainscow D.A., and Denham R.A. The risk of hematogenous infection in total joint replacements. J Bone Joint Surg Br 66 (1984) 580-582
28. Lübbeke A., Stern R., Garavaglia G., Zürcher L., and Hoffmeyer P. Differences in outcomes of obese women and men undergoing primary total hip arthroplasty. Arthritis Rheum 57 (2007) 327-334
29. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections. Am J Infect Control 16 (1988) 128-140
30. Wayne P. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing, Seventeenth informational supplement standard M100-S17; 2007.
31. Poss R., Thornhill T.S., Ewald F.C., Thomas W.H., Batte N.J., and Sledge C.B. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop Relat Res 182 (1984) 117-126
32. Owens W.D., Felts J.A., and Spitznagel Jr. E.L. ASA physical status classifications: a study of consistency of ratings. Anesthesiology 49 (1978) 239-243
33. Peduzzi P., Concato J., Feinstein A.R., and Holford T.R. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 48 (1995) 1503-1510
34. Hodgin K.E., and Moss M. The epidemiology of sepsis. Curr Pharm Des 14 (2008) 1833-1839
35. Zimmerli W., Trampuz A., and Ochsner P.E. Prosthetic-joint infections. N Engl J Med 351 (2004) 1645-1654
36. De Boer A.S., Geubbels E.L., Wille J., and Mintjes-de Groot A.J. Risk assessment for surgical site infections following total hip and total knee prostheses. J Chemother 13 (2001) 42-47
37. Wójkowska-Mach J., Jaje E., Romaniszyn D., Kasparek M., Frańczuk B., Bulanda M., et al. Comparison of SSI rates in endoarthroplasty of hip and knee in a cracow patient population and the importance of postdischarge surveillance. Infection 36 (2008) 36-40
38. Berbari E.F., Marculescu C., Sia I., Lahr B.D., Hanssen A.D., Steckelberg J.M., et al. Culture-negative prosthetic joint infection. Clin Infect Dis 45 (2007) 1113-1119
39. Coventry M.B. Treatment of infections occurring in total hip surgery. Orthop Clin North Am 6 (1975) 991-1003
40. Perl B., Gottehrer N.P., Raveh D., Schlesinger Y., Rudensky B., and Yinnon A.M. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis 29 (1999) 1483-1488
41. Uçkay I., Pittet D., Bernard L., Lew D., Perrier A., and Peter R. Antibiotic prophylaxis before invasive dental procedures in patients with arthroplasties of the hip and knee. J Bone Joint Surg Br 90 (2008) 833-838
42. Stoeckle M., Kaech C., Trampuz A., and Zimmerli W. The role of diabetes mellitus in patients with bloodstream infections. Swiss Med Wkly 138 (2008) 512-519
43. Berbari E.F., Hanssen A.D., Duffy M.C., Steckelberg J.M., Ilstrup D.M., Harmsen W.S., et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 27 (1998) 1247-1254
44. Uslan D.Z., Sohail M.R., St Sauver J.L., Friedman P.A., Hayes D.L., Stoner S.M., et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 167 (2007) 669-675
45. Marculescu C.E., and Osmon D.R. Antibiotic prophylaxis in orthopedic prosthetic surgery. Infect Dis Clin North Am 19 (2005) 931-946
46. Hoess C.M.C., and Krause M. Die Autopsie: Anachronistischer Zopf oder vernachlässigte Qualitätskontrolle?. Schweiz Med Forum 7 (2007) 278-283